Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2010
01/05/2010CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
12/2009
12/31/2009US20090328259 Polypeptides having endoglucanase activity and polynucleotides encoding same
12/31/2009US20090328255 Nitrogen limitation adaptability gene and protein and modulation thereof
12/31/2009US20090328254 Novel vip3 toxins and methods of use
12/31/2009US20090328252 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
12/31/2009US20090328251 Galactosyltransferase
12/31/2009US20090328249 Transplastomic Plants Expressing Lumen-Targeted Protein
12/31/2009US20090328248 Constitutive plant promoters
12/31/2009US20090328243 Secreted proteins as markers for cell differentiation
12/31/2009US20090326209 Method for isolating and modifying DNA from blood and body fluids
12/31/2009US20090326208 Methods and compositions for generating recombinant nucleic acid molecules
12/31/2009US20090326204 Interferon-like protein zcyto21
12/31/2009US20090326199 IFBM's to Promote the Specific Attachment of Target Analytes to the Surface of Orthopedic Implants
12/31/2009US20090326198 interfacial biomaterial (IFBM); coating to promote osteointegration of the implant, accelerating healing; includes peptide that binds to the surface of the implant, and to e.g. bone morphogenic proteins
12/31/2009US20090326197 interfacial biomaterial (IFBM); coating to promote osteointegration of the implant, accelerating healing; includes peptide that binds to the surface of the implant, and to e.g. bone morphogenic proteins
12/31/2009US20090326050 Di(uridine 5'-)tetraphosphate and salts thereof
12/31/2009US20090326049 Blocking oligos for inhibition of microrna and sirna activity and uses thereof
12/31/2009US20090326047 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
12/31/2009US20090326046 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090326045 Compositions and methods for topical delivery of oligonucleotides
12/31/2009US20090326043 Method and Compound for Antiviral (HIV) Therapy
12/31/2009US20090326042 Compounds and methods for modulating expression of crp
12/31/2009US20090326041 Compounds and methods for modulating expression of sglt2
12/31/2009US20090325944 Methods and Compositions for Modulating Glycosylation
12/31/2009US20090325883 Peptides Which Interact with Anti-Apoptotic Members of the BCL-2 Protein Family, and Uses
12/31/2009US20090325873 Human glp-1 mimetibodies, compositions, methods and uses
12/31/2009US20090325864 Novel protein and process for preparing the same
12/31/2009US20090325818 siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)
12/31/2009US20090325812 Nanoparticles having oligonucleotides attached thereto and uses therefor
12/31/2009US20090325305 Detectable threading intercalator
12/31/2009US20090325291 METHOD OF PREPARING siRNAs FOR SELECTIVE INHIBITION OF TARGET mRNA ISOTYPES
12/31/2009US20090325290 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
12/31/2009US20090325286 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325285 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325265 High eicosapentaenoic acid producing strains of yarrowia lipolytica
12/31/2009US20090325264 Engineered Delta-15-Fatty Acid Desaturases
12/31/2009US20090325238 Method of Analyzing a BRCA2 Gene in a Human Subject
12/31/2009US20090325237 Method of Analyzing a BRCA2 Gene in a Human Subject
12/31/2009US20090325228 Fungal cell wall synthesis gene
12/31/2009US20090325207 Novel phosphodiesterase and gene thereof
12/31/2009US20090325204 Compounds and methods for diagnosis and treatment of chagas disease
12/31/2009US20090325182 Methods for detecting a cyclophilin b snp associated with herda
12/31/2009US20090325181 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325172 sequencing reactions where nucleotide or nucleoside molecules modified by reversible covalent attachment of 3'-OH blocking groups thereto, are used where blocked nucleotide or nucleoside molecules are required
12/31/2009US20090325170 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure
12/31/2009US20090325169 Rnase h-based assays utilizing modified rna monomers
12/31/2009US20090325162 Fatty acid synthetase, polynucleotide encoding the same, and uses thereof
12/31/2009US20090325160 Compositions and methods for prognosis and therapy of liver cancer
12/31/2009US20090325158 5-Bromo-2'-Deoxy-Uridine Labeled Nucleotide Triphosphates and Nucleic Acid Probes and Methods of Making and Using the Same
12/31/2009US20090325157 Pathogen detection and screening
12/31/2009US20090325154 Pyrosequencing Methods and Related Compositions
12/31/2009US20090325152 Use of gene activity classifiers for the in vitro classification of gene expression profiles of patients with infectious/non-infectious multiple organ failure
12/31/2009US20090324797 Modulating plant oil levels
12/31/2009US20090324649 Leishmania vaccine using sand fly salivary immunogen
12/31/2009US20090324634 Trypanosoma Antigens, Vaccine Compositions, and Related Methods
12/31/2009US20090324631 Polyvalent Vaccine
12/31/2009US20090324623 Two-component genome flavivirus and uses thereof
12/31/2009US20090324619 Immunogenic Protein Carrier Containing An Antigen Presenting Cell Binding Domain and A Cysteine-Rich Domain
12/31/2009US20090324616 Differential cytokine expression in human cancer
12/31/2009US20090324614 Fc receptor binding proteins
12/31/2009US20090324610 Gene associated with arteriosclerotic disease, and use thereof
12/31/2009US20090324605 Interferon alpha antibodies and their uses
12/31/2009US20090324590 Myostatin antagonists
12/31/2009US20090324584 Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant
12/31/2009US20090324579 Anti-apoptotic protein antibodies
12/31/2009US20090324574 Esterases and Related Nucleic Acids and Methods
12/31/2009US20090324566 T-Cell Receptor and Nucliec Acid Encoding the Receptor
12/31/2009US20090324553 Chimeric Viral Envelopes
12/31/2009US20090324549 Proteins and/or peptides for the prevention and/or treatment of neurodegenerative diseases
12/31/2009US20090324538 Fusion molecules and IL-15 variants
12/31/2009US20090324501 Vaccine Carrier
12/30/2009WO2009158704A2 Therapeutic agents comprising elastin-like peptides
12/30/2009WO2009158591A1 Strong activation domain
12/30/2009WO2009157219A1 Method of electrochemically detecting nucleic acid with the use of dna conjugate
12/30/2009WO2009156853A2 Compounds, compositions, and methods useful for modulating the expression of histone deacetylase (hdac) gene expression and/or activity
12/30/2009WO2009155772A1 Nucleic acid enrichment device and uses thereof
12/30/2009WO2009134710A3 Methods for enhancing utrophin production via inhibition of microrna
12/30/2009WO2009131919A3 Polymerases for incorporating modified nucleotides
12/30/2009WO2009126517A3 Optimized probes and primers and methods of using same for the detection, quantification and grouping of hiv-1
12/30/2009WO2009124295A3 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
12/30/2009WO2009124150A3 Stabilized nucleic acid dark quencher-fluorophore probes
12/30/2009WO2009117547A3 Markers and methods for assessing and treating severe or persistant asthma
12/30/2009WO2009105592A3 Compositions and methods for detection of propionibacterium acnes nucleic acid
12/30/2009WO2009105260A3 Ultra-small rnas as toll-like receptor-3 antagonists
12/30/2009WO2009100342A3 Disease markers and uses thereof
12/30/2009WO2009100214A3 Induction of thyroid iodide-handling gene expression in human cancers
12/30/2009WO2009086497A3 Genetic encryption
12/30/2009WO2009086469A3 Immunomodulatory agents and methods of use
12/30/2009WO2009086428A3 Methods and compositions for increasing gene expression
12/30/2009WO2009086352A3 Cynomolgus toll-like receptor 3
12/30/2009WO2009079592A3 Modulating immune system development and function through microrna mir-146
12/30/2009WO2009061640A3 Hepatitis b virus (hbv) specific oligonucleotide sequences
12/30/2009WO2009058818A3 Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling
12/30/2009WO2009039330A3 Compositions and methods for altering the morphology of plants
12/30/2009WO2009038770A3 Detoxified recombinant botulinum neurotoxin
12/30/2009WO2009035547A3 Compositions and related methods for modulating alkaloid production by controlling pmt promoter activation mediated by transcriptional factors erf and myc
12/30/2009WO2008153772A3 Chlamydia vaccine comprising htra polypeptides
12/30/2009WO2008131215A3 Engineered phosphite dehydrogenase mutants
12/30/2009WO2008129428A3 Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
12/30/2009WO2008118385A3 Lignin reduction and cellulose increase in crop biomass via genetic engineering
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 899